Extract
Diatide Submits First New Drug Application to FDA.
LONDONDERRY, N.H.--(BW HealthWire)--Aug. 21, 1997-- Diatide, Inc. (NASDAQ: DITI) announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration for AcuTect (Kit for the preparation of Technetium Tc99m Apticide, formerly known as P280) for the detection and localization of acute venous thrombosis.
"AcuTect is the fir...See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Other documents:
32 CFR 728.1 Mission of Navy Medical Department facilities. | 22 USC 262 Sec 262p-4p Encouragement of fair labor practices | usa v andres jacobo-zavala 8th cir 2001 | levy v supt public schools 4th cir 1999 | Sentencia nº 25370, de Corte de Apelaciones de Santiago - Sala Cuenta, January 23, 2012 | Sentencia nº 4534 de Consiglio di Stato September 14 2009 | sentencia nº 3635 de consiglio di stato july 15 2009 | Sentencia nº 21921, de Corte de Apelaciones de Valparaiso - Sala Primera, April 12, 2012
